Atossa Therapeutics ATOS
NASDAQ ATOS
$2.07 -0.07 (-3.26%)
As of: Nov 11, 2026 · 1:02 PM EST

Atossa Therapeutics (ATOS) Return on Assets [ROA] (2012 - 2026)

Updated

Atossa Therapeutics' Return on Assets [ROA] was -107.40% in Q2 2026, down 64.93 percentage points from -42.46% a year earlier and down 19.40 percentage points from the prior quarter.

Analysis

Atossa Therapeutics (ATOS) Return on Assets [ROA] (2012 - 2026) Analysis & Trends

For FY2025, Return on Assets [ROA] at Atossa Therapeutics came in at -56.06%, down 26.52 percentage points from FY2024.

  • Return on Assets [ROA] has now declined for three consecutive years, though with a five-year change of +6.14 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Assets [ROA] was -29.54% in FY2024 (-2.15 pp), -27.39% in FY2023 (-7.02 pp), -20.36% in FY2022 (+2.02 pp) and -22.39% in FY2021 (+39.81 pp).
  • The Q2 2026 figure marks the lowest quarterly Return on Assets [ROA] since Q3 2020.
  • Compared with a year earlier, Return on Assets [ROA] has declined for 17 straight quarters, with an average year-over-year change of -23.84 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Assets [ROA] over five years was Q3 2021 (a gain of 103.68 percentage points); the worst was Q2 2026 (a drop of 64.93 percentage points).
  • Per Business Quant data, ATOS's Return on Assets [ROA] in the three quarters before Q2 2026 was -88.00% (Q1 2026), -65.84% (Q4 2025) and -49.26% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.08%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 7.32%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.87%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.36%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 9.80%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -7.67%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 2.00%
10 Atossa Therapeutics 21.38 Mn -98.31 Mn - -118.02%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -118.02%
Jun 30, 2026 -107.40%
Mar 31, 2026 -88.00%
Dec 31, 2025 -65.84%
Sep 30, 2025 -49.26%
Jun 30, 2025 -42.46%
Mar 31, 2025 -35.80%
Dec 31, 2024 -32.71%
Sep 30, 2024 -32.55%
Jun 30, 2024 -29.29%
Mar 31, 2024 -31.70%
Dec 31, 2023 -30.41%
Sep 30, 2023 -28.40%
Jun 30, 2023 -28.20%
Mar 31, 2023 -23.78%
Dec 31, 2022 -21.59%
Sep 30, 2022 -18.68%
Jun 30, 2022 -15.83%
Mar 31, 2022 -15.68%
Dec 31, 2021 -14.50%
API Access

Atossa Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ATOS&period=max&api_key=YOUR_API_KEY